Global Clinical Research Services (CRS) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Clinical Research Services (CRS) Market Research Report 2024
This clinical research services procurement research report offers a predictive analysis of the critical cost drivers and the current supply market trends that will facilitate a better understanding of the market from the cost perspective.
The offset of chronic ailments, increase in aging demography, and augmented spend potential are paving the way for the development of newer drugs and treatments. Consequently, the pharmaceutical industry is increasing their adoption of various clinical research services to develop new drugs while the healthcare industry is seeking services to make the treatments more affordable.
According to MRAResearch’s new survey, global Clinical Research Services (CRS) market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Research Services (CRS) market research.
Key companies engaged in the Clinical Research Services (CRS) industry include Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL and ICON, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Clinical Research Services (CRS) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Clinical Research Services (CRS) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Clinical Research Services (CRS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Labcorp
IQVIA
Syneos Health
Parexel
PRA
PPD
CRL
ICON
Segment by Type
Early Phase Services
Late Phase Services
Other Services
Cancer
Cardiovascular
CNS
Infectious Diseases
Metabolic Diseases
Other Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Research Services (CRS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
The offset of chronic ailments, increase in aging demography, and augmented spend potential are paving the way for the development of newer drugs and treatments. Consequently, the pharmaceutical industry is increasing their adoption of various clinical research services to develop new drugs while the healthcare industry is seeking services to make the treatments more affordable.
According to MRAResearch’s new survey, global Clinical Research Services (CRS) market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Research Services (CRS) market research.
Key companies engaged in the Clinical Research Services (CRS) industry include Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL and ICON, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Clinical Research Services (CRS) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Clinical Research Services (CRS) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Clinical Research Services (CRS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Labcorp
IQVIA
Syneos Health
Parexel
PRA
PPD
CRL
ICON
Segment by Type
Early Phase Services
Late Phase Services
Other Services
Segment by Application
Cancer
Cardiovascular
CNS
Infectious Diseases
Metabolic Diseases
Other Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Research Services (CRS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source